Moderna Covid-19 Vaccines For Children
- All
- News
- Videos
-
US Approves Covid Vaccines For Children As Young As 6 Months
US health authorities on Saturday cleared the Pfizer and Moderna Covid-19 vaccines for children aged five and younger, in a move President Joe Biden greeted as a "monumental step" in the fight against the virus.
-
US Approves Covid Vaccine For Children 6 Months And Above
The US Food and Drug Administration granted emergency authorization Friday for the use of Pfizer and Moderna Covid-19 vaccines in the youngest children, the final age group awaiting immunization in most countries.
-
US Health Authority Says Moderna Covid Vaccine Effective In Under-Fives
US health authorities confirmed on Friday that data provided by drug-maker Moderna on the efficacy of its Covid-19 vaccine among very young children were accurate.
-
Infant Covid Vaccine Succeeded In Trial, Says Moderna
US biotech firm Moderna on Wednesday said it was pursuing regulatory approval for its Covid vaccine in children aged six months to six years after the two-shot regimen was found to be safe and produced a strong immune response.
-
Moderna Seeks EU Approval Of Covid Vaccine For 6 To 11 Year Olds
Moderna has applied to the European Union's medicine regulator for approval of its Covid-19 vaccine for children aged six to 11, the US biotechnology company announced Tuesday.
-
UK Regulator Approves Moderna Jab For Children Aged 12-17
Britain's medicines watchdog on Tuesday said it had approved the Moderna Covid-19 vaccine for children aged 12 to 17, after previously giving the green light to Pfizer.
-
2 COVID-19 Vaccines For Young Children Show Promise In Early Trials: Study
The Moderna COVID-19 vaccine and an experimental protein-based preventive proved to be safe and showed good antibody response against SARS-CoV-2 in a trial on baby rhesus macaques, scientists say.
-
Moderna Announces Start Of Covid Vaccine Trials For Children
US manufacturer Moderna on Tuesday said it has started Covid-19 vaccine trials for children aged from 6 months to under 12 years old, with plans to enroll about 6,750 participants.
-
US Approves Covid Vaccines For Children As Young As 6 Months
US health authorities on Saturday cleared the Pfizer and Moderna Covid-19 vaccines for children aged five and younger, in a move President Joe Biden greeted as a "monumental step" in the fight against the virus.
-
US Approves Covid Vaccine For Children 6 Months And Above
The US Food and Drug Administration granted emergency authorization Friday for the use of Pfizer and Moderna Covid-19 vaccines in the youngest children, the final age group awaiting immunization in most countries.
-
US Health Authority Says Moderna Covid Vaccine Effective In Under-Fives
US health authorities confirmed on Friday that data provided by drug-maker Moderna on the efficacy of its Covid-19 vaccine among very young children were accurate.
-
Infant Covid Vaccine Succeeded In Trial, Says Moderna
US biotech firm Moderna on Wednesday said it was pursuing regulatory approval for its Covid vaccine in children aged six months to six years after the two-shot regimen was found to be safe and produced a strong immune response.
-
Moderna Seeks EU Approval Of Covid Vaccine For 6 To 11 Year Olds
Moderna has applied to the European Union's medicine regulator for approval of its Covid-19 vaccine for children aged six to 11, the US biotechnology company announced Tuesday.
-
UK Regulator Approves Moderna Jab For Children Aged 12-17
Britain's medicines watchdog on Tuesday said it had approved the Moderna Covid-19 vaccine for children aged 12 to 17, after previously giving the green light to Pfizer.
-
2 COVID-19 Vaccines For Young Children Show Promise In Early Trials: Study
The Moderna COVID-19 vaccine and an experimental protein-based preventive proved to be safe and showed good antibody response against SARS-CoV-2 in a trial on baby rhesus macaques, scientists say.
-
Moderna Announces Start Of Covid Vaccine Trials For Children
US manufacturer Moderna on Tuesday said it has started Covid-19 vaccine trials for children aged from 6 months to under 12 years old, with plans to enroll about 6,750 participants.
